Manage episode 322860158 series 2951952
Dr. Tania Small is the Vice President and Global Medical Oncology Head at GSK. She started her career as a pediatric oncologist and realized that her passion for helping patients would drastically accelerate by transitioning to the R&D side of healthcare. She did just that, as you'll hear in this episode when she describes how it felt to see her first FDA-approved medication prescribed to treat thousands more patients than she could have ever helped individually. Her latest passion is serving the GYN/ONC research community and sharing with Matthew the many new challenges and opportunities industry is tackling head-on to put the patient more at the center of care. Also, what role can women take in getting ahead of these diseases, and how can we collaborate to help patients survive and thrive? Also, what does she see as the most revolutionary biotech innovations on the horizon for women living with cancer? Medical progress can only do so much if patients have trouble accessing care, and Covid-19 has made us painfully aware of the racial and socioeconomic gaps in healthcare access. How do we break down those access barriers and help underserved communities get the services they need?
This ad-free episode of Out of Patients is made possible by our partner, GlaxoSmithKline(GSK), a science-led global healthcare company with a special purpose to improve the quality of human life by helping people do more, feel better, live longer. For more information, please visit https://www.gsk.com.